12 ms·
Patient Number One in a new cancer treatment
- rubatuga 9y agoImmunology is one of the biggest fields that are stepping up to fight cancer. In a nutshell, we are programming the patients immune system to kill its own cancer cells, a marked departure from the general toxic chemotherapy that weakened almost every dividing cell in the human body. I believe people in a few decades will look back and express disbelief at the barbaric way we tried to treat cancer.
- dekhn 9y agoor express disbelief that we didn't anticipate <fairly obvious outcome> as an unexpected side effect of immune system tailoring. <fairly obvious outcome> is likely to be "large increase in incididence of autoimmune disorders"
- rubatuga 9y agoWell if you use antibodies, they should be able to slowly be excreted and broken down after a while. I don’t believe antibodies undergo any memory effect. If you use a specific form of T cells, they should undergo the same degradation, although I guess there is a possibility that in some unknown cases it might revert to a memory cell, although to my knowledge this doesn’t happen. Lastly, since the virus used to express the receptor should only infect the cells extracted from his blood, any autoimmune response shouldn’t last (since cytotoxic T cells don’t last forever). The virus isn’t self replicating, and isn’t used to infect any other cells.
- dekhn 9y agothats a lot of "shoulds" for a complicated system.
- rubatuga 9y agoI don’t believe you have a compelling argument, any biological organism has a degree of unpredictability, but with a series of molecular checks and controls, it becomes predictable, almost deterministic. Think of how the brain works, how you have billions of cells acting the way they “should”, and acting in a predictable way allowing you to perform daily tasks. I agree we have a lot to learn and that some mistakes might be made, but that’s what testing and clinical trials is for.
- dekhn 9y agoUnfortunately, autoimmune diseases violate the assumption that biological organisms become also predictable. That's true for brains, too.
- reasonattlm 9y agoWhich might be controlled by immune ablation; safer targeted forms of destroying all immune cells would be a very good way to stop all forms of autoimmunity, and would act as a good backstop to immunotherapies in general. Right now immune ablation is pretty rough chemotherapy, but has nonetheless been shown to put multiple sclerosis and type 1 diabetes into remission. There are new approaches to targeted cell killing under development now (such as Oisin Biotechnologies' system) that should be much better, with minimal side-effects. Couple that with a cell therapy to accelerate replacement of immune cells and it looks pretty promising.
- zzalpha 9y agoWell, the flipside is that if you stop chemo, the damage to your body stops. But if the immune system over reacts, it can run out of control and kill you. I have a relative with stage IV melanoma. She was included in a research trial that used a pair of immune stimulating drugs in an attempt to get her own body to fight the cancer. What they didn't realize is she had a latent, undiagnosed autoimmune condition called vasculitis. Unfortunately, while vasculitis is normally isolated to a particular part of the body, hers was systemic. What followed was an immediate halt of the drug regimen and massive doses of steroids to get it under control. If that hadn't have worked, it would have killed her. Full stop. The condition is now fortunately under control, but she has 30% kidney function, and the steroids pushed her over to full non-insulin-dependent diabetes. She's now on a targeted therapy that, for now, has pushed her into full remission, but it's only a matter of time before the melanoma becomes resistant to the drug. The reality is, doctors do not fully understand the immune system. Period. These treatments are in many ways astonishing, but they can turn frightening very very quickly. And they don't always work, either. Unfortunately, there are no miracles, here. Not yet.
- lr4444lr 9y agoThat's true, but assuming this specific treatment doesn't reprogram the native immune system, it sounds like the side effects are much shorter and less devastating than the systemic damage of chemo, even if requiring repeated attempts.
- zzalpha 9y agoWell, given the doctors in the article flat out stated that: There was a chance that his immune system would go into overdrive, and there was a chance that the edited T-cells wouldn’t be as potent as they expected. The medical team just really couldn’t be sure what would happen. That article goes on to note all manner of side effects with this style of therapy: fever, tremors, convulsions, encephalitis... and right at the end we have this quote: He had an atypical skin growth, a chronic cough, a sinus infection, a puddle of fluid at the bottom of his lungs, a virus in his right eye, and bad heartburn. Of course, as far as side effects go, this is pretty minor. But there's no understanding of why these types of things happen in the first place because our understanding of the immune system in vivo is just not very good.
- Mz 9y agoI would like to see a more elegant means to boost the immune function, without so much of the Dr. Frankenstein element. I think supporting the immune function is the way to go, but I think we need a lighter hand, not a heavier one.
- jfarlow 9y agoIf you are directing the immune system against cells that the body perceives as 'self', then simply boosting the system to the point it attacks a cancer will likely be detrimental the patient. Cancers and other similar diseases are so difficult to address precisely because they are borne from a patient's own cells, own genome, and own systems. This therapy here is a very pointed mechanism to demonstrate to the immune system what is okay to attack, and what is not - a very particular and specific kind of guidance that a generalized 'boost' would not properly address. And in that way it actually is an elegant, precisely designed system in play here.
- Mz 9y agoCancers and other similar diseases are so difficult to address precisely because My general understanding is that they are so difficult to address because we don't really understand them. I have a condition that gets partly explained as "overactive immune response." I really hate the concept of autoimmune diseases and I hope that someday it will be mocked as "god, what those barbaric idiots believed back in the day."
- jfarlow 9y ago'Cancer' is a huge umbrella term. Some cancers we know very well, many we do not. The one's being addressed by these therapies are well enough understood to target therapeutically. Some like cervical cancer, skin and lung cancer are well enough understood to in part be prevented. But under that umbrella the reason cancers are 'hard to treat' (from the perspective of a pharmaceutical education/industry/knowledgebase that had a century of success curing invading diseases) is because cancers do not present a 'differnece' that can be exploited biochemically. Cancers are by definition a mashup and amalgamation of the components that make up a human - again very much unlike a bacteria, viral or fungal infection. You are correct though that there is still a lot for us to learn. The technologies in this article are very much a glimpse of the next steps though.
- PhasmaFelis 9y agoI'm not sure "barbaric" is the right word. It's ugly and unpleasant, but it works and it's the best hope we have for many people. "Barbaric" to me would be bleeding a patient to balance their humors; chemotherapy is more along the lines of amputating a septic limb.
- byteCoder 9y agoFive years ago, I had my own immune system rebooted to (so far) eliminate my Stage IV melanoma cancer in a trial at the National Institutes of Health. At that time, without further treatment, I probably had six to twelve months to live. In essence, the tumor infiltrating lymphocytes (TIL) adoptive cell therapy was as follows: 1. The doctors removed a melanoma tumor that was growing in my neck. 2. In the lab, white blood T cells (T lymphocytes) that were attempting to attack the cancerous tissue in my tumor were isolated into at least five different petri dishes. The white blood cells' growth was stimulated using IL-2. 3. Those samples that grew the most and attacked the cancerous tissue (2 of the samples, in my case) were then expanded to a total of 130 billion lymphocytes in the lab. 4. I returned to NIH for a week of immune system preparation, specifically the almost complete suppression of my own active immune system using harsh chemotherapy. This was to allow my body to accept the new lab-grown immune system. 5. Once my immune system was sufficiently suppressed, I received all 130 billions of the lab-grown lymphocytes. The immune system was then stimulated by having five large doses of IL-2 every eight hours over a two day period. (Note: This was hellish.) 6. After a week or so, my immune system had recovered and I was released from the NIH Clinical Center to return home. I was given an anti-biotic to take for 4 to 6 months to reduce the possibility of contracting a specific pneumonia (PCP). 7. I returned to NIH monthly for scans monthly for the first three months. After month one, my tumors had shrunk 33%. After month two, 66%. After month three, they were almost complete gone. My immune systems had essentially been immunized against some of the mutations contained in my cancerous melanoma cells. 8. I was declared NED (no evidence of disease after 15 months) and a complete responder to the treatment after 21 months. Now, almost five years post-treatment, I have had CT scans and brain MRIs every six months with still no signs of melanoma. My doctors have told me that I'm likely cured. Immunotherapy works. I chose this trial because the I liked the fact that my own immune system was being boosted to fight my cancer. Further info: https://en.wikipedia.org/wiki/Tumor-infiltrating_lymphocytes https://en.wikipedia.org/wiki/Tumor-infiltrating_lymphocytes My doctor is Dr. Steven Rosenberg of the National Cancer Institute.
- byteCoder 9y agoAlso, besides the overall success of my treatment, other than regular followup scans, I don't require any further medications of any sort. It's a one-and-done treatment. I'm certain that Big Pharma doesn't like these treatments.
- bitwize 9y agoThe manga Hellsing features a character named Alucard who is no relation to the Castlevania Alucard. This Alucard is, in fact, Dracula himself, who was defeated by Abraham van Helsing and, rather than accept destruction, swore to be a servant of the van Helsing family, who employ him as a powerful weapon against the undead. I mention this because it seems HIV is the Alucard of immunological treatments: a terrifying incurable disease which we now use as a potent weapon to fight other diseases. The thing that made it so terrifying -- its tendency to attack immune cells -- also makes it incredibly fit to purpose.
- mabbo 9y agoI'd love to see a comparison done on the news pieces we're reading today about CAR-T and compare it to the news stories a century ago as penicillin was discovered and began being used as a treatment. Everyone is afraid to over-hype this, but take a moment and consider that we're now re-wiring the human immune system to fight things it previously couldn't. That's incredible. Obligatory xkcd on the topic: https://xkcd.com/938/ https://xkcd.com/938/
- jfarlow 9y agoPenicillin :: invading diseases (bacterial/viral/fungal) CARs (& protein biotherapetuics) :: human diseases (misregulation/cancer)
- jfarlow 9y agoChimeric Antigen Receptors are an impressive first step into designed biological technologies. There are new challenges associated with their design and deployment - but there are also a lot of theoretical capabilities that are unmatched non-protein therapeutics. It's very much a new paradigm in treatment. These are 'cures' to human misregulations very much like how small molecules 'cured' patients of foreign diseases a century ago (and do not cure patients of regulatory diseases). If you want to build your own chimeric antigen receptors we've built a digital infrastructure to allow you [1]. Though we just made public our generic protein design software (thanks ShowHN! [2]), we're employing the same underlying digital infrastructure to build, evaluate, and manage CAR designs in high throughput [3]. The drug approved here was painstakingly designed by hand [4], while we think the technology now exists to permit many more such advances to be created at a much more rapid pace. [1] https://serotiny.bio/pinecone/ https://serotiny.bio/pinecone/ [2] https://news.ycombinator.com/item?id=14446679 https://news.ycombinator.com/item?id=14446679 [3] https://serotiny.bio/notes/applications/car https://serotiny.bio/notes/applications/car [4] https://serotiny.bio/notes/proteins/car19/ https://serotiny.bio/notes/proteins/car19/
- rubatuga 9y agoWow, this seems really amazing. I read some background from your show HN, but does your software mostly make DNA plasmids? How would you go about integrating that into a eukaryote? I think in the article they used a retrovirus. Also, plasmids have a maximum size for proteins, do you have a vector to incorporate larger proteins?
- jfarlow 9y agoThe software 'compiles' down to DNA - which can be produced and delivered in any form useful to clients. Most of the time that deliverable is a plasmid. The plasmid DNA is then used as a reagent to manufacture the physical retroviruses that are used to transduce the extracted T-cells which are then reimplanted into a patient. Practically, multiple plasmids, each containing a single component of a synthetic retrovirus are given to 'viral manufacturing cells', and the output is pool of virus that is infectious only once, and has DNA that encodes the CAR design as its payload. That virus is then given to the extracted T-cells, where it infects them with the viral payload and integrates its genetic payload into their genomes. Once integrated, the cells are tested to ensure they are not further infectious, then reimplated - newly 'upgraded' with DNA that encodes a synthetic CAR protein that is now capable of homing in and killing the target cancer. Getting all that payload into a plasmid is certainly an art. A lentiviral capsid has a physical pressure capacity such that it can hold <13kb of DNA. This is precisely why it's so important to have good ways of testing/pruning/evaluating new protein designs so that you can prune down a theoretical design into precisely the minimal design required for effect.
- perseusprime11 9y agoWhy can't we focus a lot of funding on this project? This is exactly the kind of thing for Government to lead rather than wasting time trying to healthcare out.
- zackmorris 9y agoI agree. Most people don't seem to realize the kind of progress that's been made in recent years with CRISPR etc. These problems are becoming data problems rather than biology/chemistry problems. The public (government) should certainly be funding many teams with small amounts of money ($10,000 to $100,000 say) rather than pouring billions/trillions of dollars into "proven winners" (big pharma) that mainly come up with therapies rather than doing basic research. Honestly I think the same argument applies to so many areas of the economy: alternative energy, space travel, growing food, and so on. We could be finding so many "cures" for relatively modest investments that our current system has actually become very expensive due to the opportunity cost of not doing so. I've spent most of my life asking what we are all working for and towards but have come to the conclusion that keeping everyone busy is the goal now, not progress.
- deorder 9y agoWhat about the following CRISPR patent problem? https://www.forbes.com/sites/jacobsherkow/2017/02/21/how-much-is-a-crispr-patent-license-worth/#3f325ed06b77 https://www.forbes.com/sites/jacobsherkow/2017/02/21/how-muc... http://www.nature.com/news/why-the-crispr-patent-verdict-isn-t-the-end-of-the-story-1.21510 http://www.nature.com/news/why-the-crispr-patent-verdict-isn... This could discourage smaller companies from picking it up (ex. to build upon it, from which in the long run everyone will profit, see open-source) and make CRISPR-based treatments more expensive / unavailable (ex. large companies owning the patents artificially inflating the price, may be even more than the old technology it replaces).
- exabrial 9y agoI do agree with what you're saying but don't downplay the healthcare talks either :/ I lost my health insurance, again, to Obamacare. But it doesn't matter because no one in my state (ks) is willing to sell individual health insurance next year... I think there are three states headed this way last time I read. So yes, the repeal of Obamacare does need to happen sadly :/ I'm hoping for a partisan solution, but at the moment members of Congress are busy promoting their political parties instead of working together.
- gozur88 9y agoI fully expect in 30 years few people will die from cancer, but instead we'll be dying from things like antibiotic immune staph and strep.
- JBReefer 9y agoAgreed. Cancer is random and having a genetic likelihood of a treatment-resistant cancer reduces the chance of that sequence spreading. Unlike cancer, bacteria and viruses mutate as they move through the population and slowly become resistant to everything we throw at them. Being treatment resistant is a help, not a hinderance to their genetic propagation. With growing global density and antibiotic abuse, it's the things like MRSA and syphilis that are likely to never disappear.
- kevinwuhoo 9y agoIf we can design CARs for cancer specific markers or have the technology to create other immunotherapies, I don't see why we couldn't do the same for any antigen including antibiotic resistant bacteria. A quick search shows that there is some work in this area already.
- omegaworks 9y ago>leukemia, lymphoma, and squamous cell skin cancer Whoa... what is the probability that you'd get all of these without being exposed to a carcinogen? >retired corrections officer I wonder if the prison he was working in was built near a superfund site. http://www.alternet.org/environment/americas-toxic-prisons-environmental-injustices-mass-incarceration http://www.alternet.org/environment/americas-toxic-prisons-e...
- URSpider94 9y agoThey mention in the article that the skin cancer appeared to be a metastasis from his bones. I expect that all of these cancers stemmed from a single source in his bone marrow.
- agumonkey 9y agoHow many of you or people you know would run away from new treatment trials ? I've been surprised to see a few people getting more than annoyed at suggesting it. "I'm not a guinea pig" was the recurrent answer.
- Grangar 9y agoIf you have no options left, I suppose it's the only sensible thing to do. Either you're 100% sure you die from cancer, or you take an unknown chance that might save you. Then again, not all people are very capable of rational thought.
- agumonkey 9y agoIt's rational in the light of people believing labs are just here to take advantage of you and try nasty chemicals on you.
- Double_a_92 9y agoCan't you just use Cannabis Oil? I heard it works 100% from my aunt on facebook. /s